US 8883161
Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant
granted A61KA61K2039/505A61P
Quick answer
US patent 8883161 (Fusion polypeptide against EB virus-induced tumor and colicin Ia mutant) held by PROTEIN DESIGN LAB, LTD. expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PROTEIN DESIGN LAB, LTD.
- Grant date
- Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/20, A61P35/00